Activatable bioactive implantable medical device and method of use

• US 20050137570A1
• Filed: 06/22/2004
• Published: 06/23/2005
• Est. Priority Date: 12/17/2003
• Status: Abandoned Application

• Current Assignee: Codman & Shurtleff Incorporated (Johnson & Johnson)
• Original Assignee: Codman & Shurtleff Incorporated (Johnson & Johnson)
• Inventors: Jones, Donald K., Pomeranz, Mark L., Lorenzo, Juan A., Sherman, Darren
• Application Number:
  US10/874,864
• Publication Number:
  US 20050137570A1
• Time in Patent Office: Days
• US Class Current: 604/500
• CPC Class Codes: A61B 17/12022 Occluding by internal devices, e.g. balloons or releasable wires plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20
• CPC Class Codes: A61B 17/12113 within an aneurysm
• CPC Class Codes: A61B 17/1215 comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
• CPC Class Codes: A61B 17/1219 expandable in contact with liquids
• CPC Class Codes: A61B 2017/12054 Details concerning the detachment of the occluding device from the introduction device
• CPC Class Codes: A61L 2300/216 with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

A medial device, such as a vascular occlusive device, which includes a support element having a compound disposed thereon which stimulates the production of vascular endothelial growth factors, and an outer barrier coating which serves to prevent a reaction between the compound and bodily fluids until the outer barrier is dissolved by applying an external agent to the outer barrier.

Claims

1. A vascular occlusion device comprising:

a support member;

a compound disposed on said support member which stimulates tissue growth; and

,

an outer barrier disposed on said compound to prevent exposure of said compound to bodily fluids when said vascular occlusion device is inserted into a blood vessel, said outer barrier exhibiting the characteristic of being inert to bodily fluid but dissolving when an external agent is applied to said outer barrier.

2. A vascular occlusion device as defined in claim 1, wherein said compound stimulates vascular endothelial tissue growth.

3. A vascular occlusion device as defined in claim 2, wherein said compound comprises a vascular endothelial growth factor.

4. A vascular occlusion device as defined in claim 1, wherein said compound comprises a basic fibroblast growth factor.

5. A vascular occlusion device as defined in claim 1, wherein said compound comprises a transforming growth factor β

.

6. A vascular occlusion device as defined in claim 2, wherein the outer barrier takes the form of a coating applied to the support member.

7. A vascular occlusion device as defined in claim 6, wherein said outer barrier is comprised of ethylene vinyl alcohol.

8. A vascular occlusion device as defined in claim 7, wherein said external agent is comprised of dimethyl sulfoxide.

9. A vascular occlusion device comprising:

a support member comprised of a compound which stimulates tissue growth; and

,

an outer barrier disposed on said support member to prevent contact between said support member and bodily fluids when said vascular occlusion device is inserted into the body, said outer barrier exhibiting the characteristic of being substantially inert to blood but exposing a portion of said compound when in the presence of an external agent.

10. A vascular occlusion device as defined in claim 9, wherein said compound stimulates vascular endothelial tissue growth.

11. A vascular occlusion device as defined in claim 10, wherein said compound comprises a vascular endothelial growth factor.

12. A vascular occlusion device as defined in claim 9, wherein said compound comprises a basic fibroblast growth factor.

13. A vascular occlusion device as defined in claim 9, wherein said compound comprises a transforming growth factor β

.

14. A vascular occlusion device as defined in claim 10, wherein the outer barrier takes the form of a coating applied to the support member.

15. A vascular occlusion device as defined in claim 14, wherein said outer barrier is comprised of ethylene vinyl alcohol.

16. A vascular occlusion device as defined in claim 15, wherein said external agent is comprised of dimethyl sulfoxide.

17. A vascular occlusion device comprising:

a support element comprising a compound which stimulates the production of vascular endothelial growth; and

,

an outer barrier comprising an activatable agent, said outer barrier covering said support element and being inert to bodily fluids and exhibiting the characteristics of initially preventing a reaction between the support element and bodily fluids when said vascular occlusion device is inserted into the body and subsequently permitting a reaction between the support element and bodily fluids.

18. A vascular occlusion device as defined in claim 17, wherein said compound comprises a vascular endothelial growth factor.

19. A vascular occlusion device comprising:

a bioactive support member which when placed within the body stimulates tissue growth when exposed to bodily fluids; and

,

a barrier for preventing a reaction between the bioactive support member and bodily fluids when said vascular occlusion device is inserted into the body, said barrier exhibiting the characteristic of being inert to bodily fluids but permitting a reaction between the bioactive support member and bodily fluids when an activating agent is applied to said barrier.

20. A vascular occlusion device as defined in claim 19, wherein said bioactive support member stimulates vascular endothelial tissue growth.

21. A vascular occlusion device as defined in claim 20, wherein said bioactive support member comprises a vascular endothelial growth factor.

22. A vascular occlusion device as defined in claim 19, wherein said bioactive support member comprises a basic fibroblast growth factor.

23. A vascular occlusion device as defined in claim 19, wherein said bioactive support member comprises a transforming growth factor β

.

24. A vascular occlusion device as defined in claim 19, wherein said barrier is comprised of ethylene vinyl alcohol.

25. A vascular occlusion device comprising:

a support element comprised of a compound which stimulates production of vascular endothelial growth factors; and

,

an outer barrier disposed on said support element to prevent exposure of said compound to bodily fluid when said vascular occlusion device is inserted into a blood vessel, said outer barrier exhibiting the characteristic of being inert to bodily fluid but dissolving when an external agent is applied to said outer barrier.

26. A vascular occlusion device as defined in claim 25, wherein said compound is comprised of a polypeptide.

27. A vascular occlusion device as defined in claim 26, wherein said compound is comprised of hypoxia-induced factor-1.

28. A vascular occlusion device as defined in claim 26, wherein the outer barrier takes the form of a coating applied to the support element.

29. A vascular occlusion device as defined in claim 28, wherein said outer barrier is comprised of ethylene vinyl alcohol.

30. A vascular occlusion device as defined in claim 29, wherein said external agent is comprised of dimethyl sulfoxide.

31. A vascular occlusion device comprising:

a support member;

a stimulation compound which stimulates the production of vascular endothelial growth factors disposed on said support member; and

,

an outer barrier disposed on said stimulation compound to prevent contact between said stimulation compound and bodily fluid when said vascular occlusion device is inserted into the body, said outer barrier exhibiting the characteristic of being substantially inert to blood but exposing a portion of said stimulation compound to bodily fluids when in the presence of an external agent.

32. A vascular occlusion device as defined in claim 31, wherein said stimulation compound is comprised of a polypeptide.

33. A vascular occlusion device as defined in claim 32, wherein said stimulation compound is comprised of hypoxia-induced factor-1.

34. A vascular occlusion device as defined in claim 31, wherein said outer barrier is comprised of ethylene vinyl alcohol.

35. A vascular occlusion device comprising:

a support element comprising a compound which stimulates the production of vascular endothelial growth factors; and

,

an outer barrier comprising an activatable agent, said outer barrier covering said support element and being inert to bodily fluids and exhibiting the characteristics of initially preventing a reaction between the support element and bodily fluids when said vascular occlusion device is inserted into the body and subsequently permitting a reaction between the support element and bodily fluids.

36. A vascular occlusion device as defined in claim 35, wherein said compound comprises a polypeptide.

37. A vascular occlusion device as defined in claim 36, wherein said compound is comprised of hypoxia-induced factor-1.

38. A vascular occlusion device as defined in claim 36, wherein said outer barrier is comprised of ethylene vinyl alcohol.

39. A vascular occlusion device comprising:

a bioactive support member which when placed within the body stimulates the production of vascular endothelial growth factors when exposed to bodily fluid; and

,

a barrier for preventing a reaction between the bioactive support member and bodily fluids when said vascular occlusion device is inserted into the body, said barrier exhibiting the characteristic of being inert to bodily fluids but permitting a reaction between the bioactive support member and bodily fluids when an activating agent is applied to said barrier.

40. A vascular occlusion device as defined in claim 39, wherein said bioactive support member is comprised of a polypeptide.

41. A vascular occlusion device as defined in claim 40, wherein said bioactive support member is comprised of hypoxia-induced factor-1.

42. A vascular occlusion device as defined in claim 41, wherein said barrier is comprised of ethylene vinyl alcohol.

43. A medical device comprising:

a support member;

a stimulation compound which stimulates the production of vascular endothelial growth factors disposed on said support member; and

,

an outer barrier disposed on said stimulation compound to prevent exposure of said stimulation compound to bodily fluid when said medical device is inserted into a blood vessel, said outer barrier exhibiting the characteristic of being substantially inert to bodily fluid but dissolving when exposed to an activation agent.

44. A medical device as defined in claim 43, wherein said stimulation compound takes the form of a coating applied to the support member.

45. A medical device as defined in claim 44, wherein said stimulation compound is comprised of a polypeptide.

46. A medical device as defined in claim 45, wherein said stimulation compound is comprised of hypoxia-induced factor-1.

47. A medical device as defined in claim 46, wherein the outer barrier takes the form of a coating applied to the stimulation compound.

48. A medical device as defined in claim 47, wherein said outer barrier is comprised of a non-water soluble material.

49. A method of treatment comprising the steps of:

providing a vascular occlusion device comprising a support member, a stimulation compound which stimulates the production of tissue growth disposed on said support member, and an outer barrier exhibiting the characteristic of normally preventing a reaction between the stimulation compound and bodily fluid and of exposing said stimulation compound to bodily fluids when an external agent is applied to said outer barrier;

inserting a delivery catheter into a blood vessel;

advancing the distal tip of the delivery catheter through the blood vessel until the distal tip is adjacent to a selected site within the blood vessel;

delivering said vascular occlusion device with the delivery catheter at the selected site; and

,

applying an external agent through the delivery catheter and into the blood vessel at the site to thereby activate said outer barrier to expose said stimulation compound to bodily fluids to thereby cause a reaction between the stimulation compound and the bodily fluid which in turn causes stimulation of the production of tissue growth.

50. A method of treatment comprising the steps of:

providing a vascular occlusion device comprising a support member comprised of a stimulation compound which stimulates the production of growth factors when the support member reacts with bodily fluids and having an outer barrier which exhibits the characteristic of normally inhibiting a reaction between said support member and bodily fluids;

inserting a delivery catheter into a blood vessel;

advancing the distal tip of the delivery catheter through the blood vessel until the distal tip is adjacent a selected site;

delivering said vascular occlusion device with the delivery catheter at the selected site; and

,

permitting bodily fluid to react with the support member to thereby expose said support member to bodily fluids to cause a reaction between the support member and bodily fluids in order to cause stimulation of the production of vascular endothelial growth factors.